| 0.549 -0.051 (-8.44%) | 05-14 11:54 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.73  |
1-year : | 0.86 |
| Resists | First : | 0.62 |
Second : | 0.74 |
| Pivot price | 0.63 |
|||
| Supports | First : | 0.44 |
Second : | 0.37 |
| MAs | MA(5) : | 0.58 |
MA(20) : | 0.64 |
| MA(100) : | 0.7 |
MA(250) : | 1.03 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 34.2 |
D(3) : | 25.2 |
| RSI | RSI(14): 40 |
|||
| 52-week | High : | 2.75 | Low : | 0.37 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HKPD ] has closed above bottom band by 7.2%. Bollinger Bands are 3.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.65 - 0.66 | 0.66 - 0.66 |
| Low: | 0.44 - 0.45 | 0.45 - 0.45 |
| Close: | 0.59 - 0.6 | 0.6 - 0.61 |
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Sat, 18 Apr 2026
Cellyan (HKPD) Stock: Is It Ready for Entry (Institutional Demand) 2026-04-18 - Index Investing - Xã Vĩnh Công
Sat, 18 Apr 2026
Cellyan (HKPD) Stock: Is It Ready for Entry (Institutional Demand) 2026-04-18 - Community Volume Signals - Cổng thông tin điện tử Tỉnh Sơn La
Sun, 12 Apr 2026
HKPD Technical Analysis & ETF Price Forecast - Intellectia AI
Fri, 03 Apr 2026
HKPD Stock Analysis: Cellyan Biotechnology Co. Ltd gains 1.59% to trade at 0.57 dollar - Cổng thông tin điện tử tỉnh Lào Cai
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 16 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 62.2 (%) |
| Held by Institutions | 0.3 (%) |
| Shares Short | 1 (K) |
| Shares Short P.Month | 2 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.46 |
| Profit Margin | -4.3 % |
| Operating Margin | 2.9 % |
| Return on Assets (ttm) | -4 % |
| Return on Equity (ttm) | -13.4 % |
| Qtrly Rev. Growth | -35.8 % |
| Gross Profit (p.s.) | 0.08 |
| Sales Per Share | 1 |
| EBITDA (p.s.) | -0.04 |
| Qtrly Earnings Growth | -83.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -9.47 |
| PEG Ratio | 0 |
| Price to Book value | 1.2 |
| Price to Sales | 0.56 |
| Price to Cash Flow | -21.71 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|